TNXP·890260839·US·equity·Healthcare - Biotechnology-13D/G
TNXP (TONIX PHARMACEUTICALS HOLDIN) is held by 52 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($13.3M), CITADEL ADVISORS LLC ($6.4M), GEODE CAPITAL MANAGEMENT, LLC ($4.3M). Net institutional sentiment: Mixed.
See how TNXP's score breaks down across 4 SEC sources
Showing 1-20 of 57
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer